We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
(+14%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1.3
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$269M |
| 2 |
Stericycle Inc
SRCL
|
+$141M |
| 3 |
Marathon Oil Corporation
MRO
|
+$108M |
| 4 |
ChampionX
CHX
|
+$103M |
| 5 |
Spirit AeroSystems
SPR
|
+$95.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitrans Midstream Corporation Common Stock
ETRN
|
+$149M |
| 2 |
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.8M |
| 3 |
Southwestern Energy Company
SWN
|
+$56.7M |
| 4 |
Union Pacific
UNP
|
+$24.2M |
| 5 |
US Steel
X
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.91% |
| 2 | Technology | 19.62% |
| 3 | Healthcare | 14.36% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Staples | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Full Truck Alliance
YMM
$8.88B
| $103K | ﹤0.01% |
11,473
-385,717
| -97% | -$2.96M |
2024 Q2
1 quarter
|
|
402
ZoomInfo Technologies
GTM
$1.13B
| $103K | ﹤0.01% |
10,000
-55,000
| -85% | -$576K |
2024 Q2
1 quarter
|
|
403
DELISTED
HilleVax
HLVX
| $91.1K | ﹤0.01% |
51,779
+4,809
| +10% | +$12.3K |
2022 Q2
9 quarters
|
|
404
PUT
Synchrony
SYF
$23.7B
| $83.2K | ﹤0.01% |
21,900
| – | – |
2024 Q2
1 quarter
|
|
405
PUT
Neurocrine Biosciences
NBIX
$14.5B
| $72.8K | ﹤0.01% |
+30,000
| New | +$4.11M |
2024 Q3
0 quarters
|
|
406
PUT
Vornado Realty Trust
VNO
$6.28B
| $72K | ﹤0.01% |
33,500
| – | – |
2024 Q2
1 quarter
|
|
407
PUT
iRhythm Holdings
IRTC
$3.52B
| $71.9K | ﹤0.01% |
+25,000
| New | +$1.99M |
2024 Q3
0 quarters
|
|
408
CALL
Viking Therapeutics
VKTX
$3.63B
| $68K | ﹤0.01% |
20,000
+6,400
| +47% | +$375K |
2024 Q1
2 quarters
|
|
409
PUT
Novo Nordisk
NVO
$171B
| $67K | ﹤0.01% |
+10,000
| New | +$1.33M |
2024 Q3
0 quarters
|
|
410
CALL
Arvinas
ARVN
$500M
| $66K | ﹤0.01% |
+20,000
| New | +$522K |
2024 Q3
0 quarters
|
|
411
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $65K | ﹤0.01% |
+113,000
| New | +$406K |
2024 Q3
0 quarters
|
|
412
PUT
Tesla
TSLA
$1.51T
| $64K | ﹤0.01% |
+50,000
| New | +$11.4M |
2024 Q3
0 quarters
|
|
413
CALL
CRISPR Therapeutics
CRSP
$5.16B
| $63.8K | ﹤0.01% |
30,000
+5,000
| +20% | +$254K |
2023 Q4
3 quarters
|
|
414
PUT
Thor Industries
THO
$3.3B
| $62.5K | ﹤0.01% |
+100,000
| New | +$10.2M |
2024 Q3
0 quarters
|
|
415
PUT
Praxis Precision Medicines
PRAX
$7.26B
| $60.6K | ﹤0.01% |
+25,000
| New | +$1.35M |
2024 Q3
0 quarters
|
|
416
CALL
Insmed
INSM
$22B
| $50.3K | ﹤0.01% |
18,000
-42,000
| -70% | -$3.1M |
2024 Q2
1 quarter
|
|
417
PUT
Sarepta Therapeutics
SRPT
$1.89B
| $43.5K | ﹤0.01% |
10,000
-5,000
| -33% | -$691K |
2024 Q2
1 quarter
|
|
|
418
CALL
Praxis Precision Medicines
PRAX
$7.26B
| $41.6K | ﹤0.01% |
+13,000
| New | +$702K |
2024 Q3
0 quarters
|
|
419
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
| $41.3K | ﹤0.01% |
129,160
-4,173
| -3% | -$1.43K |
2024 Q1
2 quarters
|
|
420
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$3.59B
| $40.1K | ﹤0.01% |
+25,000
| New | +$1.37M |
2024 Q3
0 quarters
|
|
421
CALL
Agios Pharmaceuticals
AGIO
$1.9B
| $37.8K | ﹤0.01% |
20,000
-25,000
| -56% | -$1.14M |
2024 Q1
2 quarters
|
|
|
XAGEW
422
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
| $33K | ﹤0.01% |
371,250
| – | – |
2023 Q3
4 quarters
|
|
423
PUT
Uber
UBER
$146B
| $31.8K | ﹤0.01% |
19,000
| – | – |
2023 Q4
3 quarters
|
|
424
CALL
Moderna
MRNA
$89.8B
| $30.9K | ﹤0.01% |
15,000
-1,000
| -6% | -$91.8K |
2023 Q4
3 quarters
|
|
425
CALL
ARK Genomic Revolution ETF
ARKG
$2.18B
| $29.8K | ﹤0.01% |
+70,000
| New | +$1.78M |
2024 Q3
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2024 Portfolio in Review
As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.
- UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
- UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
- UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
- UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
- UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
- UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.
Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.